Literature DB >> 27501964

MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update.

A Molassiotis1, M Aapro2, J Herrstedt3, R Gralla4, F Roila5.   

Abstract

Keywords:  Antiemetic guidelines; Cancer; Clinical guidelines; Nausea and vomiting

Year:  2016        PMID： 27501964     DOI： 10.1007/s00520-016-3324-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  3 in total

1.  Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

Authors:  R J Gralla; D Osoba; M G Kris; P Kirkbride; P J Hesketh; L W Chinnery; R Clark-Snow; D P Gill; S Groshen; S Grunberg; J M Koeller; G R Morrow; E A Perez; J H Silber; D G Pfister
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

Review 2.  Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Authors:  F Roila; J Herrstedt; M Aapro; R J Gralla; L H Einhorn; E Ballatori; E Bria; R A Clark-Snow; B T Espersen; P Feyer; S M Grunberg; P J Hesketh; K Jordan; M G Kris; E Maranzano; A Molassiotis; G Morrow; I Olver; B L Rapoport; C Rittenberg; M Saito; M Tonato; D Warr
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).

Authors:  M Aapro; A Molassiotis; M Dicato; I Peláez; Á Rodríguez-Lescure; D Pastorelli; L Ma; T Burke; A Gu; P Gascon; F Roila
Journal:  Ann Oncol       Date:  2012-03-06       Impact factor: 32.976
  3 in total
  9 in total

1.  Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Authors:  Rudolph M Navari; Rui Qin; Kathryn J Ruddy; Heshan Liu; Steven F Powell; Madhuri Bajaj; Leah Dietrich; David Biggs; Jacqueline M Lafky; Charles L Loprinzi
Journal:  N Engl J Med       Date:  2016-07-14       Impact factor: 91.245

Review 2.  Nausea and Vomiting in Advanced Cancer.

Authors:  Rudolph M Navari
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

3.  Co-occurring Gastrointestinal Symptoms Are Associated With Taste Changes in Oncology Patients Receiving Chemotherapy.

Authors:  Alissa Nolden; Paule V Joseph; Kord M Kober; Bruce A Cooper; Steven M Paul; Marilyn J Hammer; Laura B Dunn; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2019-07-23       Impact factor: 3.612

4.  Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis.

Authors:  Zhonghan Zhang; Yaxiong Zhang; Gang Chen; Shaodong Hong; Yunpeng Yang; Wenfeng Fang; Fan Luo; Xi Chen; Yuxiang Ma; Yuanyuan Zhao; Jianhua Zhan; Cong Xue; Xue Hou; Ting Zhou; Shuxiang Ma; Fangfang Gao; Yan Huang; Likun Chen; Ningning Zhou; Hongyun Zhao; Li Zhang
Journal:  Oncologist       Date:  2018-01-12

5.  Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk.

Authors:  Mototsugu Shimokawa; Toshinobu Hayashi; Junichi Nishimura; Taroh Satoh; Mutsumi Fukunaga; Reiko Matsui; Yasushi Tsuji; Fumitaka Mizuki; Takahiro Kogawa
Journal:  BMC Cancer       Date:  2021-10-16       Impact factor: 4.430

6.  Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial.

Authors:  Mette Stie; Charlotte Delmar; Birgitte Nørgaard; Lars Henrik Jensen
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.575

7.  Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center.

Authors:  Vijay M Patil; Arun Chandrasekharan; Dilip Harindran Vallathol; Mridul Malhotra; Ram Abhinav; Priti Agarwal; Anu Rajpurohit; Raees Tonse; Atanu Bhattacharjee; Rakesh Jalali
Journal:  Neurooncol Pract       Date:  2019-04-19

8.  Helping patients discuss CINV management: development of a Patient Charter.

Authors:  Annie Young; Pascale Dielenseger; Paz Fernandez Ortega; Dolores Fernandez Perez; Philippa Jones; Elaine Lennan; Eileen O'Donovan; Sue Sharp; Alison Whiteford; Lilian Wiles
Journal:  Ecancermedicalscience       Date:  2013-03-14

9.  Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Authors:  Antony J Mersiades; Annette Tognela; Paul S Haber; Martin Stockler; Nicholas Lintzeris; John Simes; Iain McGregor; Ian Olver; David J Allsop; Craig Gedye; Adrienne C Kirby; Rachael L Morton; Peter Fox; Stephen Clarke; Karen Briscoe; Morteza Aghmesheh; Nicole Wong; Anna Walsh; Carmel Hahn; Peter Grimison
Journal:  BMJ Open       Date:  2018-09-12       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.